Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
Submitted by
admin
on August 16, 2013 - 10:42am
Source:
Bloomberg
News Tags:
insulin
diabetes
Sanofi
Novo Nordisk
Levemir
Lantus
Victoza
Headline:
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
Do Not Allow Advertisers to Use My Personal information
